Replies to post #92290 on Avid Bioservices Inc (CDMO)

[Robert C Jonson]

or the 1st line lung cancer trial MOS

Don't forget that the 1st line NSCLC control group MOS hasn't evented, either, so we could get good 1st line MOS for our treatment arms that will be criticized because they're not overwhelmingly better than the control group.